## TJX: The TJX Companies, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -2.3% below STRENGTH zone (3.0-6.0%); PEG 3.02 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($145.18)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. TJX seen extending sales momentum as pricing power boosts margins â€“ BofA**
- Source: Proactive financial news | 20251204T191718 | Bullish | Relevance: 100%
- Bank of America analysts believe that TJX Companies Inc. (NYSE:TJX) is well-positioned for continued growth due to its consistent outperformance, pricing power, international expansion, and growing store count. The off-price retailer, which owns TJ Maxx, Marshalls, and HomeGoods, is expected to maintain low- to mid-single-digit comparable sales growth. BofA reiterated its "Buy" rating and a $168 price objective on TJX stock.

**2. Barclays Adjusts Price Target on TJX to $172 From $168, Maintains Overweight Rating**
- Source: MarketScreener | 20251204T122219 | Somewhat-Bullish | Relevance: 100%
- Barclays has increased its price target for TJX Companies from $168 to $172, reiterating an Overweight rating on the stock. This adjustment reflects an updated outlook from the analyst firm for the discount retail giant. The news follows several other analyst adjustments for TJX in recent days.

**3. Will TJX Q3 Sales Momentum Continue as Marmaxx and HomeGoods Shine?**
- Source: TradingView | 20251203T193656 | Bullish | Relevance: 100%
- TJX Companies, Inc. (TJX) reported strong 5% consolidated comparable sales in Q3 fiscal 2026, driven by impressive performances in its Marmaxx apparel (6% growth) and HomeGoods (5% growth) divisions. The company's growth is attributed to higher customer transactions, increased average basket size, disciplined pricing, and broad-based category strength, suggesting sustained operating momentum. While Walmart (WMT) also saw solid comparable sales, and Burlington Stores (BURL) experienced a rebound in mid-October, TJX's price performance and valuation metrics appear favorable.

**4. Bernstein Boosts TJX Companies (TJX) Price Target Following Strong Quarterly Results**
- Source: Finviz | 20251203T013700 | Bullish | Relevance: 100%
- Bernstein SocGen Group raised its price target for TJX Companies to $155 from $152, maintaining an Outperform rating due to strong quarterly results. The firm highlighted TJX's effective off-price business strategy, which led to a 5% improvement in comparable sales and a 40 basis point increase in pre-tax profit margin. Bernstein expects further EPS outperformance from the company, recognized as a consistent strong performer in retail.

**5. Bernstein Boosts TJX Companies (TJX) Price Target Following Strong Quarterly Results**
- Source: Insider Monkey | 20251203T013700 | Bullish | Relevance: 100%
- Bernstein SocGen Group increased its price target for The TJX Companies, Inc. (NYSE:TJX) to $155 from $152, maintaining an Outperform rating due to strong quarterly results. The firm highlighted TJX's impressive 5% improvement in consolidated comparable sales and a 40 basis point increase in pre-tax profit margin, driven by its off-price business strategy and effective advertising. Bernstein expressed confidence in TJX's long-term prospects, expecting further EPS outperformance given its consistent strong performance in retail.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 16, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Barclays | $172 | $168 | +2% |
| 2025-12-04 | Baird | $165 | $160 | +3% |
| 2025-12-04 | Telsey Advisory | $170 | $170 | 0% |
| 2025-11-20 | UBS | $181 | $172 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Barclays | main | Overweight |
| 2025-12-04 | Baird | main | Outperform |
| 2025-12-04 | Telsey Advisory | main | Outperform |
| 2025-11-20 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 9 ($8.48M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (+0.8%)
- Blackrock Inc.: 9.1% (+1.4%)
- State Street Corpora: 4.3% (-0.8%)
- JPMORGAN CHASE & CO: 3.5% (+80.3%)
- FMR, LLC: 3.0% (-0.7%)

### Key Risks

1. Insider selling cluster: $8.5M in recent transactions.
2. Valuation stretched: PEG 3.0x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 16 raises (avg +4%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 3.02 signals overvaluation risk, limited margin of safety. Forward P/E 29.3x stretched relative to 10% growth. Quality metrics strong (ROE 58%, ROA 12%). Balance sheet: $1.0B free cash flow. Insider selling cluster ($8.5M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $174.9B |
| Beta | 0.76 |
| 52W Range | $112.10 - $157.83 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.02 |
| Forward P/E | 29.3 |
| Current P/E | 32.2 |
| YoY Growth | 10.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.7% to -2.3% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.3pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 59. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.26% (CS: 29) | Weak |
| RSI_14 | 59.0 | Neutral |
| MACD Histogram | 0.03 | Bullish |
| vs SMA20 | 1.014x | Above |
| vs SMA50 | 1.038x | Above |
| vs SMA200 | 1.140x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $150.30
- **Stop Loss:** $145.18 (3.4% risk)
- **Target:** $155.42 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 195
- **Position Value:** $29,308.50
- **Portfolio %:** 29.31%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-02-25 (Est: $1.37)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.22 | $1.28 | +5.0% |
| 2025Q3 | $1.01 | $1.10 | +8.5% |
| 2025Q2 | $0.91 | $0.92 | +0.8% |
| 2025Q1 | $1.17 | $1.23 | +5.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*